Certain Shares of SynAct Pharma AB are subject to a Lock-Up Agreement Ending on 11-JUN-2023. These Shares will be under lockup for 181 days starting from 12-DEC-2022 to 11-JUN-2023.

Details:
In connection with the Directed Share Issue, the Company has undertaken, with customary exceptions, not to issue additional shares for a period of 180 calendar days after closing of the Directed Share Issue. Board members and persons of the management holding shares and/or warrants have undertaken not to sell any shares in the Company for a period of 90 calendar days after closing of the Directed Share Issue, with customary exceptions. During the lock-up period, the Company's management and board of directors may however sell shares to cover individual tax liabilities.